Sign in to tag this notice and share notes on it with your team.
Winston AI writes a plain-English brief of every opportunity — what the buyer wants, and what affects whether to bid. It's free in every Scout workspace. Sign in to see it.
Spot-IT Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot in-service evaluation (ISE) for Severe Combined Immuno-Deficiency (SCID) in 3 Screening laboratories.
This is essential for NHSE's ongoing newborn screening statutory requirement, and directly impacts on patient care.
Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to Immunoivd AB commencing 01.10.2025
| Lot | Title | Value |
|---|---|---|
| 1 | Lot 1 | — |
| Title | Supplier | Value | Awarded |
|---|---|---|---|
| Provision of Assay Kits for SCID Evaluation - SPOTit ImmunoIVD | ImmunoIVD | £523,357 | — |